China keeps getting better. Lots of new news there with downstream positive implications - the Professor Zhen appointment, the MPS Drugs of Abuse Conference (spreading the word!), the Chinese patents (serious about 'killing' competition), and the Ketamine developments.
BUT THE BIG ONE IS THE INDICATION THAT SIYI WILL PROVIDE 'DETAILED PRODUCT SALES PROJECTIONS IN THE MARCH-JULY PERIOD'.
Based on the list of targeted markets on SiYi's web site, these are potentially very big indeed. And only 3-6 months away from getting these details.
Also agree with you about Bioscreens. Despite the delay, this could provide very healthy revenues from the 2nd Qtr next year.
And Oraline 8 - yes - best to take a little longer to get the technology absolutely right. But new significant markets are clearly expected here.
Just a matter of waiting til March - and then having a fun ride.
Of course, Mexico could m,aterialise at any time.
SBN Price at posting:
0.5¢ Sentiment: LT Buy Disclosure: Held